ArticlePDF Available

Testing and Linkage to Care Outcomes for a Clinician-Initiated Rapid HIV Testing Program in an Urban Emergency Department

Authors:

Abstract and Figures

The urban emergency department is an important site for the detection of HIV infection. Current research has focused on strategies to increase HIV testing in the emergency department. As more emergency department HIV cases are identified, there need to be well-defined systems for linkage to care. We conducted a retrospective study of rapid HIV testing in an urban public emergency department and level I trauma center from June 1, 2008, to March 31, 2010. The objectives of this study were to evaluate the increase in the number of tests and new HIV diagnoses resulting from the addition of targeted testing to clinician-initiated diagnostic testing, describe the demographic and clinical characteristics of patients with newly diagnosed HIV infection, and assess the effectiveness of an HIV clinic based linkage to care team. Of 96,711 emergency department visits, there were 5340 (5.5%) rapid HIV tests performed, representing 4827 (91.3%) unique testers, of whom 62.4% were male and 60.8% were from racial/ethnic minority groups. After the change in testing strategy, the median number of tests per month increased from 114 to 273 (p=0.004), and the median number of new diagnoses per month increased from 1.5 to 4 (p=0.01). From all tests conducted, there were 65 new diagnoses of HIV infection (1.2%, 95% confidence interval [CI] 0.9%, 1.5%). The linkage team connected over 90% of newly diagnosed and out-of-care HIV-infected patients to care. In summary, the addition of targeted testing to diagnostic testing increased new HIV case identification, and an HIV clinic-based team was effective at linkage to care.
Content may be subject to copyright.
Testing and Linkage to Care Outcomes
for a Clinician-Initiated Rapid HIV Testing Program
in an Urban Emergency Department
Katerina A. Christopoulos, M.D., M.P.H.,
1
Beth Kaplan, M.D.,
2
David Dowdy, M.D., Ph.D.,
3
Barbara Haller, M.D., Ph.D.,
4
Patricia Nassos, Ph.D.,
4
Marguerite Roemer, B.A.,
4
Teri Dowling, M.A., M.P.H.,
5
Diane Jones, R.N.,
1
and C. Bradley Hare, M.D.
1
Abstract
The urban emergency department is an important site for the detection of HIV infection. Current research has
focused on strategies to increase HIV testing in the emergency department. As more emergency department
HIV cases are identified, there need to be well-defined systems for linkage to care. We conducted a retro-
spective study of rapid HIV testing in an urban public emergency department and level I trauma center from
June 1, 2008, to March 31, 2010. The objectives of this study were to evaluate the increase in the number of tests
and new HIV diagnoses resulting from the addition of targeted testing to clinician-initiated diagnostic testing,
describe the demographic and clinical characteristics of patients with newly diagnosed HIV infection, and
assess the effectiveness of an HIV clinic based linkage to care team. Of 96,711 emergency department visits,
there were 5340 (5.5%) rapid HIV tests performed, representing 4827 (91.3%) unique testers, of whom 62.4%
were male and 60.8% were from racial/ethnic minority groups. After the change in testing strategy, the
median number of tests per month increased from 114 to 273 ( p=0.004), and the median number of new
diagnoses per month increased from 1.5 to 4 ( p=0.01). From all tests conducted, there were 65 new diagnoses
of HIV infection (1.2%, 95% confidence interval [CI] 0.9%, 1.5%). The linkage team connected over 90% of
newly diagnosed and out-of-care HIV-infected patients to care. In summary, the addition of targeted testing to
diagnostic testing increased new HIV case identification, and an HIV clinic-based team was effective at linkage
to care.
Introduction
The urban emergency department is a key site for the
detection of undiagnosed HIV infection. Marginalized
and vulnerable populations (e.g., racial/ethnic minorities, the
socioeconomically disadvantaged) at higher risk for HIV
frequently use the emergency department as their primary or
only source of care.
1
In addition, studies have found that some
patients diagnosed with HIV have visited the emergency
department on prior occasions.
2,3
Finally, the yield of HIV
testing in the emergency department may be greater relative
to other medical testing sites.
4
For these reasons, emergency
departments have played a prominent role in the im-
plementation of the 2006 Centers for Disease Control and
Prevention (CDC) guidelines recommending routine HIV
screening for all persons aged 13–64 years in areas where the
HIV prevalence is above 0.1%.
5
As more emergency departments undertake rapid HIV
testing efforts, they have used different strategies with regard
to patient selection. The 2007 National Emergency Depart-
ment HIV Testing consortium noted that the word ‘‘routine’’
as used in the CDC guidelines could refer either to choosing
patients for testing without regard to risk factors or to less
exceptional testing practices, such as opt-out consent.
6
Thus,
the consortium made explicit the following patient selection
strategies: diagnostic testing, which is based on clinical signs
or symptoms, targeted screening, which focuses on a defined
subpopulation thought to have a higher risk of infection than
1
HIV/AIDS Division,
2
Department of Emergency Medicine, San Francisco General Hospital, University of California San Francisco, San
Francisco, California.
3
Department of Internal Medicine,
4
Department of Laboratory Medicine, University of California San Francisco, San Francisco, California.
5
HIV Prevention Section, San Francisco Department of Public Health, San Francisco, California.
AIDS PATIENT CARE and STDs
Volume 25, Number 7, 2011
ªMary Ann Liebert, Inc.
DOI: 10.1089/apc.2011.0041
439
the general population, and nontargeted screening, in which
any patient within the available population may be tested. In
addition, emergency department HIV testing programs have
used different staffing strategies,
7
ranging from the exclusive
use of ancillary staff to offer and perform testing to incorpo-
rating testing fully into the duties of existing staff.
4,8–10
The optimal emergency department testing strategy in
terms of staffing and patient selection remains unknown, but
studies suggest that the colocation of HIV care in the same
hospital as the emergency department may facilitate linkage
to care.
11
To our knowledge, this is the first study to assess the
effectiveness of a linkage to care team based in a hospital HIV
clinic, as opposed to the emergency department social
workers, HIV counselor/testers, or public health staff used by
many emergency department HIV testing programs.
12,13
In
addition, programs that have chosen to rely on clinician-ini-
tiated testing may seek strategies for increasing the number of
tests performed. Thus, the objectives of this study were to: (1)
describe and evaluate the addition of targeted testing to a
model of clinician-initiated diagnostic testing in order to in-
crease the number of HIV tests performed; (2) characterize
new diagnoses of HIV infection with regard to demographics
and CD4 cell count, and (3) assess linkage to care outcomes for
newly diagnosed as well as out-of-care HIV-infected patients.
Methods
Study design
Using retrospective chart and database review, we evalu-
ated test outcomes, population characteristics, and linkage to
care outcomes for an emergency department rapid HIV test-
ing program that was funded in part by a CDC demonstration
project designed to increase testing among groups dispro-
portionately affected by HIV. The dates of analysis were June
1, 2008, through March 31, 2010.
Setting and program development
San Francisco General Hospital (SFGH) is a 300-bed public
safety net hospital for the city and county of San Francisco that
provides care to an urban, underserved population. The
emergency department is a level I trauma center with ap-
proximately 55,000 annual patient visits.
In May 2006, SFGH eliminated the requirement for written
consent for HIV testing and added HIV antibody testing to the
routine laboratory order form.
14
In response to the CDC
guidelines issued in September 2006 on routinizing HIV
testing in medical settings,
5
the SFGH HIV clinic convened
meetings with key stakeholders, including hospital adminis-
tration, the hospital laboratory, the emergency department,
and the San Francisco Department of Public Health on how to
expand hospital capacity for HIV testing. In February 2007 the
hospital switched its entire HIV testing platform to central
laboratory-based rapid testing on venipuncture specimens.
This service was made available 24 h per day, 7 days per
week, with results reported in the electronic medical record
(EMR) within 1–2 h after specimen receipt in the laboratory.
Prior to the new testing platform rollout, the HIV clinic
committed to expanding an existing linkage to care team to
the emergency department and other hospital testing sites in
order to assist with disclosure of positive results, handle all
follow-up appointments, and conduct medical and social
work intakes. This team consisted of a registered nurse, a
social work associate, and a nurse practitioner.
Testing protocol
From February 2007 through November 2008, clinicians
could initiate HIV testing for patients they suspected of hav-
ing signs or symptoms of HIV infection, i.e., diagnostic test-
ing. In June 2008, the CDC awarded the emergency
department HIV testing program a grant to increase the
number of patients tested. This funding was used to hire a
testing program coordinator, who facilitated a series of in-
services among emergency department physicians and staff
to raise awareness of the availability of HIV testing, and to
support the linkage to care team. Working together, the
emergency department and the HIV clinic launched an ex-
panded testing effort with revised criteria for testing on De-
cember 1, 2008 (World AIDS Day). Clinical presentations
consistent with HIV infection were listed and systematically
disseminated to emergency department clinicians on a lami-
nated pocket card. In addition, clinicians were encouraged to
undertake targeted testing of two groups of patients: (a) pa-
tients with HIV risk factors and (b) patients slated for inpa-
tient admission, regardless of their presenting complaints. If
concern existed for acute HIV infection and a rapid test was
negative, quantitative HIV viral load testing was available.
All patients age 13 and over were potentially eligible for HIV
testing in the emergency department.
Nurses drew blood and the hospital laboratory performed
rapid HIV antibody testing (Uni-Gold Recombigen HIV Test,
Trinity Biotech, Bray, Ireland) on plasma or heparin speci-
mens. Negative rapid test results were considered negative
and patients were given written materials on HIV testing
and prevention. Positive rapid test results were reported as
‘‘preliminary positive’ in the EMR and the specimen was
retested with enzyme immunoassay (EIA; Genetic Systems
HIV-1/HIV-2 Plus O EIA, Bio-Rad, Redmond, WA) and
confirmatory immunofluorescence (IFA; Fluorognost HIV-1
IFA, Sanochemia Pharmazeutika, Vienna, Austria) with re-
sults available in 1–3 days. If EIA and IFA were both nega-
tive, the rapid ‘‘preliminary positive’ test result was deemed
a false-positive, and a final HIV antibody result was reported
as negative. If EIA and IFA were both positive, a final HIV
antibody result was reported as positive. In cases where the
EIA and IFA results were discrepant, specimens were sent to
the San Francisco Department of Public Health laboratory
for repeat EIA/IFA and Western blot testing. Clinicians
disclosed both negative and ‘‘preliminary positive’ rapid
test results prior to emergency department discharge.
Patients with preliminary positive rapid test results received
packets with resources for follow-up, including drop-in
appointment times in the HIV clinic for confirmatory test
results within 1–3 days. The hospital laboratory also notified
the linkage to care team of all preliminary positive rapid
antibody test results to ensure complete follow-up of all
patients. The linkage team met patients in person if notified
during business hours and otherwise contacted patients
within 1 business day. The testing program coordinator
provided regular feedback to emergency department clini-
cians on outcomes for patients diagnosed in the emergency
department, including clinic attendance and antiretroviral
therapy initiation.
440 CHRISTOPOULOS ET AL.
Data collection and analysis
Data were obtained from the hospital laboratory on all
emergency department rapid HIV antibody tests from June 1,
2008 to March 31, 2010. Descriptive statistics were used to cal-
culate proportions with confidence intervals. The Wilcoxon
rank sum test was used to compare the median number of tests
and new HIV diagnoses per month before and after the ex-
panded program launch. Demographic data on patients un-
dergoing testing was obtained from the EMR. The v
2
test was
used to assess associations between demographic characteristics
and a positive rapid test result. The emergency department HIV
testing program database was queried for additional informa-
tion on subjects with positive rapid tests results, including rapid
test disclosure, prior HIV diagnosis, confirmatory test results,
sexual orientation, housing status, CD4cell count, and time to
linkage to care for new diagnoses. Linkage to care was defined
as one HIV-related outpatient visit. All analyses were con-
ducted in Stata SE/10. The Committee on Human Research at
the University of California San Francisco approved this study.
Results
There were 96,711 emergency department visits during the
observation period, during which 5340 (5.5%) rapid HIV an-
tibody tests were performed, representing 4827 (91.3%) un-
ique patients. There were 16,662 inpatient admissions (17.2%
of emergency department visits), with a median of 738 ad-
missions per month. Of the HIV antibody tests performed,
2430 (45.5%) were on patients who were admitted to the
hospital. After the expanded testing launch on December 1,
2008, the number of tests increased from a median of 114 tests
per month to 273 tests per month, p=0.004 (Fig. 1).
The first rapid test result for each patient is shown in Table
1. Rapid test results were positive for 126 testers (2.6%, 95%
confidence interval [CI] 2.2%, 3.1%), of which 10 were false-
positive, resulting in 116 confirmed cases of HIV infection.
The median age of testers was 44 years, (interquartile range
[IQR] 31–55 years). Women accounted for nearly 40% of tes-
ters but individuals with positive rapid test results were more
likely to be male ( p<0.001).
Of the 116 confirmed cases of HIV infection, 55 individuals
had known HIV infection, 58 patients had newly diagnosed
HIV infection, and 3 patients were suspected new HIV diag-
noses, as they had no record of a previous positive test (2
patients left the emergency department prior to disclosure
and 1 was intubated in the emergency department and died
during hospitalization). In addition to the 61 patients without
a prior known HIV diagnosis, 3 patients presented with
symptoms consistent with acute retroviral syndrome and
were diagnosed with acute HIV infection based on negative
rapid HIV antibody test results and HIV RNA levels higher
than 500,000 copies per milliliter. Furthermore, 1 patient with
a negative HIV test tested HIV positive on a repeat emergency
department visit, for a total of 65 new emergency department
HIV diagnoses out of the 5340 tests (1.22%: 95% CI, 0.94%–
1.55%). The median number of new HIV diagnoses increased
from 1.5 per month to 4 per month during the study period
p=0.01 (Fig. 1). Patients with newly diagnosed HIV infection
were 76.9% male and 37% white (Table 1). The median CD4
cell count was 268 cells per microliter, with 40% of patients
having CD4 cell counts under 200 cells per microliter.
Of the 65 patients with newly diagnosed HIV infection, 58
patients received results at the time of testing and 49 patients
were eligible for linkage to outpatient care. Reasons for inel-
igibility were discharge to a skilled nursing facility after in-
patient admission (n=3), incarceration at time of testing
(n=2), private insurance incompatible with the publicly fun-
ded SFGH HIV clinic (n=2), death during inpatient admission
FIG. 1. Number of rapid
HIV tests and new HIV diag-
noses by month, June 2008 to
March 2010.
EMERGENCY DEPARTMENT HIV TESTING 441
(n=1), and out-of-county residence (n=1). Forty-six patients
(93.9%, 95% CI: 83.1, 98.7%) were successfully linked to care,
with 73% linked by 7 days, 84% linked by 30 days, and 90% by
90 days. Of the 7 patients whose results were not disclosed at
the time of the test, 4 were able to be contacted with results
after discharge and 1 presented to the emergency department
at a later date; 4 of these patients were also linked to care. Of
the 55 patients with known HIV infection, the majority
identified as in care (n=39), while a few had out-of-county
residence (n=2) or were incarcerated (n=1). Two patients had
unknown care status. Of the remaining 11 patients, 10 (90.9%,
95% CI: 58.7%, 99.8%) were successfully relinked to care.
Discussion
A clinician-initiated diagnostic testing model utilizing the
hospital laboratory and dedicated linkage to care staff has
been described as a successful way to implement and sustain
HIV testing in the emergency department.
13
We present data
to support this claim. In addition, we are the first to describe a
successful linkage mechanism based in the hospital HIV
clinic, rather than the emergency department. We also dem-
onstrate that additional new diagnoses of HIV infection can be
identified through the implementation of strategies other than
hiring ancillary staff to conduct testing, namely by re-em-
phasizing clinical indicators of HIV infection and expanding
testing to admitted and high-risk patients. These efforts
helped create a ‘‘culture change’ among busy emergency
department clinicians with regard to incorporating HIV test-
ing into their everyday practice. In addition, external funding
was used to support the linkage to care team, as concern about
patient follow-up has been a commonly cited barrier to cli-
nician-initiated emergency department HIV testing.
15
The
effort of the program coordinator and the linkage team cor-
responded to 2 full-time equivalent positions (FTEs). The
program’s cost effectiveness is reported separately.
16
In our study, the linkage to care team achieved rates of
success exceeding 90% for both newly diagnosed and out-of-
Table 1. Characteristics of Patients Undergoing Rapid HIV Testing and Testing Newly HIV Positive
in the San Francisco General Hospital Emergency Department, June 2008–March 2010
Total tested,
n(%)
Positive rapid test,
n(% of total with
a positive rapid test)
v
2
Test, p
Confirmed rapid test,
n(% of total with
a confirmed rapid test)
Confirmed HIV
infection, newly
diagnosed, n(%)
a
Total 4827 (100%) 126 (2.6%) 116 (2.4%) 65 (100%)
Age categories (years)
a
13–24 653 (13.5%) 9 (1.4%) 7 (1.1%) 6 (9.2%)
25–44 1791 (37.1%) 66 (3.7%) p=0.001 61 (3.4%) 33 (50.8%)
45–64 1961 (40.7%) 46 (2.4%) 43 (2.2%) 23 (35.4%)
>65 418 (8.7%) 5 (1.2%) 5 (1.2%) 3 (4.6%)
Gender
Male 3014 (62.4%) 103 (3.4%) p<0.001 96 (3.2%) 50 (76.9%)
Female
b
1813 (37.6%) 23 (1.3%) 20 (1.1%) 15 (23.1%)
Race/ethnicity
White 1692 (35.0%) 24 (37.0%)
Black 1348 (27.9%) 16 (24.6%)
Latino 988 (20.5%) 14 (21.5%)
Asian/Pacific Islander 597 (12.4%) 10 (15.4%)
Other/unknown 202 (4.2%) 1 (1.5%)
Sexual orientation
Gay/bisexual 29 (44.6%)
Heterosexual 23 (35.4%)
Unknown 13 (20.0%)
Housing status
Permanent (own/rent) 32 (49.2%)
Temporary (e.g., SRO) 7 (10.8%)
Homeless/shelter 23 (35.4%)
Unknown 3 (4.6%)
Median CD4 cell count
c,d
268
IQR (65, 472)
CD4 cell count <200
Yes 23 (40.0%)
No 36 (60.0%)
Admitted to hospital
Yes 29 (44.6%)
No 26 (55.4%)
a
New diagnoses include three patients with acute HIV infection (rapid test negative, quantitative viral load >500,000 copies/mL) and one
patient who tested positive on a subsequent emergency department visit.
b
Includes 5 male-to-female transgender patients.
c
CD4 cell counts available for 59/65 patients.
d
CD4 cell counts in cells per microliter.
SRO, single room occupancy; IQR, interquartile range.
442 CHRISTOPOULOS ET AL.
care HIV patients, although studies have shown that con-
nection to care does not necessarily mean patients stay in
care.
17
Although a small number of patients left the emer-
gency department before disclosure of positive rapid test re-
sults, most of these patients were contacted by the linkage
team. Even though the turnaround time of the rapid test was
one to two hours after specimen receipt in the laboratory, the
main barrier to disclosure was discharging patients before test
results were available, either because patients wanted to leave
or because of overcrowding in the emergency department.
The high proportion of patients with previously diagnosed
HIV infection in our study is notable, and consistent with
other studies.
9
Reasons for this finding merit further investi-
gation. Most of these patients did not have prior HIV test
results available in the electronic medical record, though a
minority did. It may be that patients do not initially disclose
their HIV status; they do not believe their diagnosis; they lack
documentation of HIV status; or they seek reengagement in
care.
The optimal approach to emergency department-based
HIV testing remains uncertain.
18
A recent study found that
nontargeted testing identified only a modestly increased
number of new HIV diagnoses compared to physician-
initiated diagnostic testing, despite large increases in the
number of patients tested.
19
A previous blinded study in the
SFGH emergency department found that the prevalence of
HIV infection was 8.0%, of whom 0.9% had unknown HIV
infection.
20
While our data indicate that emergency depart-
ment clinicians can identify populations with a prevalence of
undiagnosed HIV infection greater than 1%, the additional
yield of non-targeted screening in this setting is unknown.
Limitations of our data are that we do not know testing rates
by category of clinician (e.g., attending, resident) nor we do
know the rates and yield of diagnostic versus targeted testing,
which in many cases may overlap. However, using the
magnitude of the increase in testing allows us to define a
reasonable ‘‘upper bound’ of the proportion of patients tested
via targeted criteria: (273–114)/273 =58%.
One important goal of testing in medical settings is to
identify ‘‘hidden’ populations with HIV infection—those
who would not otherwise be diagnosed in a timely fashion.
The demographic characteristics of patients with newly
identified HIV infection in the SFGH emergency department
differ noticeably from newly identified HIV cases in
San Francisco at large. In 2008, those newly diagnosed with
HIV in San Francisco were nearly 90% male, at least 80% were
men who have sex with men, and half were white.
21
In
contrast, in our study, new HIV diagnoses were nearly one
quarter female or male-to-female transgender, nearly two
thirds were racial/ethnic minorities, and approximately one
third were heterosexual-identified. In addition, the median
CD4 cell count was relatively low at the time of diagnosis.
Given these findings, it is our opinion that public hospital
emergency department-based testing may identify HIV in-
fection that might go undiagnosed by other HIV testing
systems.
Rates of clinician-initiated emergency department rapid
HIV antibody testing and identification of new HIV cases can
be increased by adding a targeted testing component to di-
agnostic testing. The integration of laboratory rapid testing
with a linkage to care team was an effective strategy for
connecting newly diagnosed and out-of-care HIV-infected
patients to care in our study. These programmatic features
should be explored in other settings.
Acknowledgments
The authors would like to thank Clarissa Ospina-Norvell
and Alida Marrero-Calderon for their dedication in linking
HIV-infected patients to care, Maria Bahn-Tigaoan for pro-
gram coordination, Noah Carraher for program monitoring
data, and Margaret Wong for the laboratory data used in this
analysis. The San Francisco General Hospital HIV testing
program was supported by CDC grant PS07-768 ‘‘Expanded
and Integrated Human Immunodeficiency Virus (HIV) Test-
ing for Populations Disproportionately Affected by HIV,
Primarily African-Americans.’’ This publication was made
possible by grant number UL1 RR024131 from the National
Center for Research Resources (NCRR), a component of the
National Institutes of Health (NIH) and the NIH Roadmap for
Medical Research. Its contents are solely the responsibility of
the authors and do not necessarily represent the official view
of NCRR. Information on NCRR is available at www.ncrr
.nih.gov/. Information on Re-engineering the Clinical Re-
search Enterprise can be obtained from http://nihroadmap
.nih.gov/clinicalresearch/overview-translational.asp. This
work was supported by the National Institutes of Health T32
AI60530 and K23 MH092220-01 (KAC).
Author Disclosure Statement
No competing financial interests exist.
References
1. Garcia TC, Bernstein AB, Bush MA. Emergency department
visitors and visits: Who used the emergency room in 2007?
NCHS data brief, no 38. Hyattsville, MD: National Center
for Health Statistics, 2010. www.cdc.gov/nchs/data/
databriefs/db38.pdf (Last accessed March 7, 2011).
2. Missed opportunities for earlier diagnosis of HIV infection—
South Carolina, 1997–2005. MMWR Morb Mortal Wkly Rep
2006;55:1269–1272.
3. White DA, Warren OU, Scribner AN, Frazee BW. Missed
opportunities for earlier HIV diagnosis in an emergency
department despite an HIV screening program. AIDS Pa-
tient Care STDs 2009;23:245–250.
4. Christopoulos KA, Schackman BR, Lee G, Green RA,
Morrison EA. Results from a New York City emergency
department rapid HIV testing program. J Acquir Immune
Defic Syndr 2010;53:420–422.
5. Branson BM, Handsfield HH, Lampe MA, et al. Revised
recommendations for HIV testing of adults, adolescents, and
pregnant women in health-care settings. MMWR Recomm
Rep. 2006;55:1–17; quiz CE11–14.
6. Lyons MS, Lindsell CJ, Haukoos JS, et al. Nomenclature and
definitions for emergency department human immunodefi-
ciency virus (HIV) testing: Report from the 2007 conference
of the National Emergency Department HIV Testing Con-
sortium. Acad Emerg Med 2009;16:168–177.
7. Rothman RE, Lyons MS, Haukoos JS. Uncovering HIV in-
fection in the emergency department: A broader perspective.
Acad Emerg Med 2007;14:653–657.
8. Brown J, Shesser R, Simon G. Establishing an ED HIV
screening program: lessons from the front lines. Acad Emerg
Med 2007;14:658–661.
EMERGENCY DEPARTMENT HIV TESTING 443
9. White DA, Scribner AN, Schulden JD, Branson BM, Heffel-
finger JD. Results of a rapid HIV screening and diagnostic
testing program in an urban emergency department. Ann
Emerg Med 2009;54:56–64.
10. Walensky RP, Arbelaez C, Reichmann WM, et al. Revising
expectations from rapid HIV tests in the emergency de-
partment. Ann Intern Med 2008;149:153–160.
11. Marks G, Gardner LI, Craw J, Crepaz N. Entry and retention
in medical care among HIV-diagnosed persons: A meta-
analysis. AIDS 2010;24:2665–2678.
12. Calderon Y, Leider J, Hailpern S, et al. High-volume rapid
HIV testing in an urban emergency department. AIDS Pa-
tient Care STDs 2009;23:749–755.
13. Haukoos JS, Hopkins E, Eliopoulos VT, et al. Development
and implementation of a model to improve identification of
patients infected with HIV using diagnostic rapid testing in
the emergency department. Acad Emerg Med 2007;14:1149–
1157.
14. Zetola NM, Klausner JD, Haller B, Nassos P, Katz MH.
Association between rates of HIV testing and elimination of
written consents in San Francisco. JAMA 2007;297:1061–
1062.
15. Arbelaez C, Wright EA, Losina E, et al. Emergency provider
attitudes and barriers to universal HIV testing in the emer-
gency department. J Emerg Med (in press).
16. Dowdy D, Rodriguez, R, Hare, CB, Kaplan, B. Cost-effec-
tiveness of targeted HIV screening in an urban emergency
department. Acad Emerg Med (in press).
17. Torian LV, Wiewel EW. Continuity of HIV-related medical
care, New York City, 2005–2009: Do patients who initiate
care stay in care? AIDS Patient Care STDs 2011;25:79–88.
18. Merchant RC, Waxman MJ. HIV screening in health care
settings: Some progress, even more questions. JAMA 2010;
304:348–349.
19. Haukoos JS, Hopkins E, Conroy AA, et al. Routine opt-out
rapid HIV screening and detection of HIV infection in
emergency department patients. JAMA 2010;304:284–292.
20. Zetola NM, Kaplan B, Dowling T, et al. Prevalence and
correlates of unknown HIV infection among patients seeking
care in a public hospital emergency department. Public
Health Rep 2008;123(Suppl 3):41–50.
21. San Francisco Department of Public Health. HIV/AIDS ep-
idemiology annual report 2008. www.sfdph.org/dph/files/
reports/RptsHIVAIDS/AnnlReport2008-20090630.pdf (Last
accessed March 7, 2011).
Address correspondence to:
Katerina A. Christopoulos, M.D., M.P.H.
HIV/AIDS Division
San Francisco General Hospital
995 Potrero Avenue
Building 80, Ward 84
Box 0874
San Francisco, CA 94114
E-mail: christopoulosk@php.ucsf.edu
444 CHRISTOPOULOS ET AL.
... In conjunction with our community partners, we designed the T2C Model to provide enhanced, longitudinal clinical and community-based support alongside the SFDPH case and contact investigation services to any participant of the Unidos en Salud Study who tested PCRpositive for SARS-CoV-2 (Fig 1) [26]. In addition to using a community partnership approach, the T2C Model also drew upon our prior experiences and lessons learned from designing and implementing large scale programs to facilitate low-barrier HIV testing and linkage-to-care [30][31][32]. The objectives of the T2C Model were to: (1) provide longitudinal medical, social and emotional support to low-income individuals who tested positive for COVID-19 in order to address potential barriers for them and their households to safely self-isolate and quarantine throughout the duration of the recommended period of 10 days or more (Fig 1, Table 1); (2) provide direct and ongoing support to COVID-19 positive participants to enroll in health insurance and to establish or re-connect with a primary care provider and access community resources in order to create a foundation to support their positive physical and mental health beyond the demonstration project (Fig 1, Table 1); and, (3) create an effective and sustainable community-based model utilizing CHWs that could be implemented in other communities to support the needs of low-income persons testing positive for COVID-19. ...
... CHWs were provided a stipend for their work. Healthcare providers included bilingual social workers, nurses and physicians who had extensive experience in providing care and support to highly vulnerable populations [31,32]. The T2C team had a community hub in the Mission neighborhood and a clinical hub at an outpatient clinic at San Francisco General Hospital. ...
Article
Full-text available
Background After a COVID-19 diagnosis, vulnerable populations face considerable logistical and financial challenges to isolate and quarantine. We developed and evaluated a novel, community-based approach (‘Test-to-Care’ Model) designed to address these barriers for socioeconomically vulnerable Latinx individuals with newly diagnosed COVID-19 and their households. Methods This three-week demonstration project was nested within an epidemiologic surveillance study in a primarily Latinx neighborhood in the Mission district of San Francisco, California. The Test-to-Care model was developed with input from community members and public health leaders. Key components included: (1) provision of COVID-19-related education and information about available community resources, (2) home deliveries of material goods to facilitate safe isolation and quarantine (groceries, personal protective equipment and cleaning supplies), and (3) longitudinal clinical and social support. Newly SARS-CoV-2 PCR-positive participants were eligible to participate. Components of the model were delivered by the Test-to-Care team, which was comprised of healthcare providers and community health workers (CHWs) who provided longitudinal clinic- and community-based support for the duration of the isolation period to augment existing services from the Department of Public Health (DPH). We evaluated the Test-to-Care Model using the Reach, Effectiveness, Adoption, Implementation, Maintenance (RE-AIM) Framework and drew upon multiple data sources including: programmatic data, informal interviews with participants and providers/CHWs and structured surveys among providers/CHWs. Results Overall, 83 participants in the surveillance study were diagnosed with COVID-19, of whom 95% (79/83) were Latinx and 88% (65/74) had an annual household income <$50,000. Ninety-six percent (80/83) of participants were reached for results disclosure, needs assessment and DPH linkage for contact tracing. Among those who underwent an initial needs assessment, 45% (36/80) were uninsured and 55% (44/80) were not connected to primary care. Sixty-seven percent (56/83) of participants requested community-based CHW support to safely isolate at their current address and 65% (54/83) of all COVID-19 participants received ongoing community support via CHWs for the entire self-isolation period. Participants reported that the intervention was highly acceptable and that their trust increased over time–this resulted in 9 individuals who disclosed a larger number of household members than first reported, and 6 persons who requested temporary relocation to a hotel room for isolation despite initially declining this service; no unintended harms were identified. The Test-to-Care Model was found to be both acceptable and feasible to providers and CHWs. Challenges identified included a low proportion of participants linked to primary care despite support (approximately 10% after one month), and insufficient access to financial support for wage replacement. Conclusions The Test-to-Care Model is a feasible and acceptable intervention for supporting self-isolation and quarantine among newly diagnosed COVID-19 patients and their households by directly addressing key barriers faced by socioeconomically vulnerable populations.
... (pre-post studies) [31][32][33][34]; three (23%) were experimental studies, including one non-randomized experimental study [35] and two controlled trials [36,37]. Six (46%) were cohort studies [38][39][40][41][42][43]. ...
Article
Full-text available
We conducted a systematic review and meta-analysis of interventions targeting linkage to HIV care in the US, Canada, and Europe. We searched six databases (PubMed, Embase, Cochrane Library, Web of Science and CINAHL). Inclusion criteria were English language studies in adults in the US, Canada, or Europe, published January 1, 2010 to January 1, 2021. We synthesized interventions by type and linkage to care outcome. The outcome was cumulative incidence of 3-month linkage. We estimated cumulative incidence ratios of linkage with 95% confidence intervals (CIs). We screened 945 studies; 13 met selection criteria (n = 1 from Canada, n = 1 from Ukraine, n = 11 from the US) and were included after full text review (total 37,549 individuals). The cumulative incidence of 3-month linkage in the intervention group was 0.82 (95% CI 0.68–0.94) and control group 0.71 (95% CI 0.50–0.90); cIR of linkage for intervention versus control was 1.30 (95% CI 1.13, 1.49). Interventions to improve linkage to care after HIV diagnosis warrant further attention.
... The positive correlation between the proportion of linkage and timeframe was expected, and confirmed in the studies that compared the proportions for different time thresholds (Christopoulos et al., 2011;Delpech et al., 2013). For example, Keller, Yehia, Eberhart, and Brady (2013) measured a proportion of linkage for lab tests of 56.9% for 30 days, 72.0% for three months, 77.6% for six months, and 81.6% for one year. ...
Article
Poor engagement into HIV care limits the effectiveness of highly active antiretroviral therapies (HAART) to improve survival and reduce transmission. The design of effective interventions to enhance linkage to care is dependent on evidence about rates of entry into HIV care. This is a systematic review and meta-analysis on linkage measurement and its determinants in the late era of HAART (post-2003), in high-income countries. We searched the PubMed and Web of Science databases, restricting our sample to the late HAART era (post-2003) until February 2016, and to high-income countries. We retained only studies that produced quantified outcomes. We rejected the studies with a high risk of bias, and followed a standard meta-analytic approach. Because there was a high heterogeneity ( I2 > 90%), the aggregated findings were based on a random-effects model. A total of 43 studies were identified, all of them following a cohort of patients newly diagnosed until referred to specialized care. For a one-month period, the meta-proportion was 71.1% (IC95%: 61.0%–81.2). For a three-month duration, the meta-proportion of linkage to care was 77.0% (IC95%: 75.0%–79.0). For a one-year period, the meta-proportion was 76.3% (IC95%: 54.2%–98.4%). The proportions were lower when lab tests were used as referral indicator, with a pooled meta-proportion of 76.7% (IC95%: 73.0%–80.4), in comparison to a value of 80.8% (IC95%: 68.7%–92.9) for consultations. Being black or male were the most commonly observed determinants of delayed entry into care. Young people, injecting drug users, people with low socioeconomic status, or at a less advanced stage of disease also experienced lower proportions of timely linkage. Timely engagement into care is below 80% and specific sub-groups are particularly at risk of late entry. These findings confirm earlier evidence that linkage to care remains low, and that efforts should focus on vulnerable populations.
Article
Despite considerable improvement in human immunodeficiency virus (HIV) knowledge and treatment in the last 3 decades, the overall number of people living with HIV (PLHIV) is still rising with up to one quarter being unaware of their HIV status. Early HIV diagnosis and treatment prolongs life, reduces transmission, improves quality of life, and is a cost-effective public health intervention. The emergency department (ED) sees a large number of patients from marginalized and traditionally underserved populations in whom HIV is known to be more prevalent and who may not attend traditional services because of either cultural reasons or because of a chaotic lifestyle. This article discusses the two main approaches to screening; 'Opt-out' screening offers testing routinely in all clinical settings, and 'Targeted' screening offers testing to individuals presenting with indicator conditions. There are many studies of 'Opt-out' ED HIV screening in urban areas of high-HIV prevalence. However, little is known about the effectiveness of 'targeted' HIV screening, especially in areas of low prevalence. This review discusses the background to HIV screening in the ED and reviews the evidence around 'targeted' HIV screening in adult EDs in different HIV prevalence settings, concluding that targeted HIV screening at the ED can be impactful, cost-effective, and well accepted in the ED population, but its long-term implementation requires extra funding and increased staffing resource limiting its application in low resource setting. Despite most evidence being from areas of high-HIV prevalence, targeted screening might also be appropriate in low-HIV prevalence areas.
Preprint
Full-text available
Background: After a COVID-19 diagnosis, vulnerable populations face considerable logistical and financial challenges to isolate and quarantine. We developed and evaluated a novel, community-based approach (Test-to-Care Model) designed to address these barriers for socioeconomically vulnerable Latinx individuals with newly diagnosed COVID-19 and their households. Methods: This three-week demonstration project was nested within an epidemiologic surveillance study in a primarily Latinx neighborhood in the Mission district of San Francisco, California. The Test-to-Care model was developed with input from community members and public health leaders. Key components included: (1) provision of COVID-19-related education and information about available community resources, (2) home deliveries of material goods to facilitate safe isolation and quarantine (groceries, personal protective equipment and cleaning supplies), and (3) longitudinal clinical and social support. Newly SARS-CoV-2 PCR-positive participants were eligible to participate. Components of the model were delivered by the Test-to-Care team which was comprised of healthcare providers and community health workers (CHWs) who provided longitudinal clinic- and community-based support for the duration of the isolation period to augment existing services from the Department of Public Health (DPH). We evaluated the Test-to-Care Model using the Reach, Effectiveness, Adoption, Implementation, Maintenance (RE-AIM) Framework and drew upon multiple data sources including: programmatic data, informal interviews with participants and providers/CHWs and structured surveys among providers/CHWs. Results: Overall, 83 participants in the surveillance study were diagnosed with COVID-19, of whom 95% (79/83) were Latinx and 88% (65/74) had an annual household income <$50,000. Ninety-six percent (80/83) of participants were reached for results disclosure, needs assessment and DPH linkage for contact tracing. Among those who underwent an initial needs assessment, 45% (36/80) were uninsured and 55% (44/80) were not connected to primary care. Sixty-seven percent (56/83) of participants requested community-based CHW support to safely isolate at their current address and 65% (54/83) of all COVID-19 participants received ongoing community support via CHWs for the entire self-isolation period. Participants reported that the intervention was highly acceptable and that their trust increased over time - this resulted in 9 individuals who disclosed a larger number of household members than first reported, and 6 persons who requested temporary relocation to a hotel room for isolation despite initially declining this service; no unintended harms were identified. The Test-to-Care Model was found to be both acceptable and feasible to providers and CHWs. Challenges identified included a low proportion of participants linked to primary care despite support (approximately 10% after one month), and insufficient access to financial support for wage replacement. Conclusions: The Test-to-Care Model is a feasible and acceptable intervention for supporting self-isolation and quarantine among newly diagnosed COVID-19 patients and their households by directly addressing key barriers faced by vulnerable populations.
Article
The incidence of syphilis infections is on the rise, particularly among African American men and men who have sex with men, and it is reaching epidemic levels in these communities throughout the United States. Although syphilis is relatively inexpensive to treat and cure and is a predictor for HIV incidence among men and transgender women who have sex with men, rates of co-screening for syphilis are low in the emergency department setting, with a dearth of literature on this topic since the 1990s and early 2000s. In this case study, we describe an operational model for routine syphilis screening implemented in June 2017 at the University Hospitals Cleveland Medical Center in Cleveland, Ohio. We describe the advantages of screening using a reverse testing algorithm rather than the traditional method and the necessity of partnering with the Cleveland Department of Public Health for both diagnostic and follow-up logistics.
Article
Full-text available
Background: Human immunodeficiency virus (HIV) infection continues to expand worldwide and a significant proportion of infection is still undiagnosed. Recent studies have addressed the impact and feasibility of 'opt-out' HIV screening in Emergency Departments (EDs) in urban settings at high HIV prevalence, whereas little is known about the yield of implementing 'targeted' HIV testing especially in low-prevalence areas. Objective: The present study undertakes a scoping review of research carried out on the implementation of targeted HIV screening in adult EDs to determine the impact, feasibility and acceptability of HIV testing in different HIV prevalence settings. Design: Online databases (EMBASE, MEDLINE) were used to identify papers published between 2000 to 2020. A threeconcept search was employed with HIV (HIV, Human immunodeficiency virus infection, HIV infections), targeted testing (Target, screening or testing) and emergency medicine (Emergency Service, emergency ward, A&E, accident and emergency or Emergency Department) (28th February 2020). Only full-text articles written in English, French, Spanish or Italian and using impact and/or feasibility and/or acceptability of the program as primary or secondary outcomes were analysed. Results: The search returned 416 articles. Of these, 12 met inclusion criteria and were included in the final review. Most of the included studies were carried out in the United States (n=8; 67%) and in areas of high HIV prevalence (n=11; 92%). Three (20%) were randomized control studies. While the rate of newly diagnosed HIV cases varied widely (0.03-2.2%), likely due to methodological heterogeneity between studies, the linkage of new HIV diagnosis was often high (80-100%) and median CD4+ cell count was always greater than 200 cells per microliter. Targeted HIV screening was found to be cost-effective (out of 2 studies) and well accepted by participants (out 2 studies). Conclusions: Targeted HIV screening at the ED can be impactful, feasible and well accepted, but often requires extra funding and staff. Most previous work has focused on areas of high disease prevalence. Keywords: HIV; early diagnosis; emergency department; low-prevalence areas; public health; targeted screening.
Article
Full-text available
Of the 37 million people estimated to be living with HIV globally in 2017, about 24.7 million were in the sub-Saharan Africa region, which has been and remains worst affected by the epidemic. Enrolment of newly diagnosed individuals into care in the region, however, remains poor with up to 54% not being linked to care. Linkage to care is a very important step in the HIV cascade as it is the precursor to initiating antiretroviral therapy (ART), retention in care, and viral suppression. A systematic review was conducted to gather information regarding the strategies that have been documented to increase linkage to care of Persons living with HIV(PLHIV) in urban areas of sub-Saharan Africa. An electronic search was conducted on Scopus, Cochrane central, CINAHL Plus, PubMed and OpenGrey for linkage strategies implemented from 2006. A total of 189 potentially relevant citations were identified, of which 7 were eligible for inclusion. The identified strategies were categorized using themes from literature. The most common strategies included: health system interventions (i.e. comprehensive care, task shifting); patient convenience and accessibility (i.e. immediate CD4 count testing, immediate ART initiation, community HIV testing); behavior interventions and peer support (i.e. assisted partner services, care facilitation, mobile phone appointment reminders, health education) and incentives (i.e. non-cash financial incentives and transport reimbursement). Several strategies showed favorable outcomes: comprehensive care, immediate CD4 count testing, immediate ART initiation, and assisted partner services. Assisted partner services, same day home-based ART initiation, combination intervention strategies and point-of-care CD4 testing significantly improved linkage to care in urban settings of sub-Saharan African region. They can be delivered either in a health facility or in the community but should be facilitated by health workers. There is, however, the need to conduct more linkage-specific studies in the sub-region.
Article
Early diagnosis of persons infected with human immunodeficiency virus (HIV) through diagnostic testing and screening is a critical priority for individual and public health. Emergency departments (EDs) have an important role in this effort. As EDs gain experience in HIV testing, it is increasingly apparent that implementing testing is conceptually and operationally complex. A wide variety of HIV testing practice and research models have emerged, each reflecting adaptations to site-specific factors and the needs of local populations. The diversity and complexity inherent in nascent ED HIV testing practice and research are associated with the risk that findings will not be described according to a common lexicon. This article presents a comprehensive set of terms and definitions that can be used to describe ED-based HIV testing programs, developed by consensus opinion from the inaugural meeting of the National ED HIV Testing Consortium. These definitions are designed to facilitate discussion, increase comparability of future reports, and potentially accelerate wider implementation of ED HIV testing.
Article
Objectives: Infection with the human immunodeficiency virus (HIV) continues to expand in nontraditional risk groups, and the prevalence of undiagnosed infection remains relatively high in the patient populations of urban emergency departments (EDs). Unfortunately, HIV testing in this setting remains uncommon. The objectives of this study were 1) to develop a physician-based diagnostic rapid HIV testing model, 2) to implement this model in a high-volume urban ED, and 3) to prospectively characterize the patients who were targeted by physicians for testing and determine the proportions who completed rapid HIV counseling, testing, and referral; tested positive for HIV infection; and were successfully linked into medical and preventative care. Methods: An interdisciplinary group of investigators developed a model for performing physician-based diagnostic rapid HIV testing in the ED. This model was then evaluated using a prospective cohort study design. Emergency physicians identified patients at risk for undiagnosed HIV infection using clinical judgment and consensus guidelines. Testing was performed by the hospital's central laboratory, and clinical social workers performed pretest and posttest counseling and provided appropriate medical and preventative care referrals, as defined by the model. Results: Over the 30-month study period, 105,856 patients were evaluated in the ED. Of these, 681 (0.64%; 95% confidence interval [CI] = 0.60% to 0.69%) were identified by physicians and completed rapid HIV counseling, testing, and referral. Of the 681 patients, 15 (2.2%; 95% CI = 1.2% to 3.6%) patients tested positive for HIV infection and 12 (80%; 95% CI = 52% to 96%) were successfully linked into care. Conclusions: A physician-based diagnostic HIV testing model was developed, successfully implemented, and sustained in a high-volume, urban ED setting. While the use of this model successfully identified patients with undiagnosed HIV infection in the ED, the overall level of testing remained low. Innovative testing programs, such as nontargeted screening, more specific targeted screening, or alternative hybrid methods, are needed to more effectively identify undiagnosed HIV infection in the ED patient population.
Article
Although targeted screening of patients at high risk for human immunodeficiency virus (HIV) infection in the emergency department (ED) improves patient outcomes and may prevent HIV transmission, ED-based screening programs incur additional costs and have thus not been widely scaled up. The objective of this study was to evaluate the cost-effectiveness of ED-based targeted HIV screening as implemented in actual practice. This was a cost-utility analysis of a rapid HIV screening program in an urban ED. Physicians were encouraged to screen patients undergoing inpatient admission or who had HIV risk factors. The authors measured costs directly and estimated quality-adjusted life expectancy using chart review, literature assumptions, and mathematical modeling. Incremental cost utility was evaluated from a societal perspective using a lifetime time horizon. From June 2008 through September 2009, a total of 3,766 HIV tests were ordered (235 tests per month), of which an estimated 2,406 (64%) represented screening in patients without HIV-related signs or symptoms. Nineteen (0.8%) patients were newly diagnosed through screening during the study period, of whom nine (47%) were eligible for antiretroviral therapy (ART) and maintained consistent outpatient follow-up. Estimated screening costs were 82,300peryear,or82,300 per year, or 45.53 per screening test, of which 28.01(6228.01 (62%) was for program management. Targeted screening prevented an estimated 2.1 HIV transmission events over 16 months. Per patient screened, targeted screening saved 112 (95% uncertainty range [UR] = 20to20 to 225) and resulted in 2.71 quality-adjusted life-days gained (95% UR = 1.71 to 4.01). Cost-utility was most sensitive to the prevalence of undiagnosed HIV in the screened population. Targeted HIV screening, as implemented in an urban ED, is cost saving and increases quality-adjusted life expectancy.
Article
In this era of effective antiretroviral therapy, early diagnosis of HIV and timely linkage to and retention in care are vital to survival and quality of life. Federal guidelines recommend regular monitoring of HIV-related laboratory parameters and initiation of antiretroviral treatment at specified thresholds. We used routinely reported laboratory data to measure intervals between visits by New York City residents newly diagnosed with HIV July 1 to September 30, 2005, and initiating care within 3 months of diagnosis. We measured regular care (≥1 visit every 6 months) and retention in care (last visit ≤6 months before close of analysis) through June 30, 2009. Patients were followed for 45-48 months. Seventy-seven percent (650/842) of patients initiated care within 3 months of diagnosis; 609 (93.7%) made at least one subsequent visit; 45.4% had regular care. Risk factors for not receiving regular care included age 13-24 versus 50+ (adjusted odds ratio [AOR] 3.0, 95% confidence interval [CI] 1.5, 6.0), black race (AOR 2.0, 95% CI 1.4,2.8), eligibility for antiretroviral treatment (AOR 1.5, 95% CI 1.1, 2.2), and injection drug use (IDU; AOR = 2.7. 95% CI 1.0, 7.1). In a time-to-event analysis, risk factors for loss to care were age 13-24 versus 50+ at diagnosis (adjusted hazard ratio [AHR] 1.9, 95% CI 1.1, 3.4), non-hospital site of care (AHR 1.4, 95% CI 1.0, 2.0) and early stage (non-AIDS) disease (AHR 1.4, 95% CI 1.0, 2.0). The analysis demonstrates how mandated reporting of HIV-related laboratory tests provides surveillance systems with the capacity to monitor utilization of care, identify deficits, and evaluate progress in programs designed to facilitate retention in care.
Article
A 'test and treat' strategy to reduce HIV transmission hinges on linking and retaining HIV patients in care to achieve the full benefit of antiretroviral therapy. We integrated empirical findings and estimated the percentage of HIV-positive persons in the United States who entered HIV medical care soon after their diagnosis; and were retained in care during specified assessment intervals. We comprehensively searched databases and bibliographic lists to identify studies that collected data from May 1995 through 2009. Separate meta-analyses were conducted for entry into care and retention in care (having multiple HIV medical visits during specified assessment intervals) stratified by methodological variables. All analyses used random-effects models. Overall, 69% [95% confidence interval (CI) 66-71%, N = 53 323, 28 findings] of HIV-diagnosed persons in the United States entered HIV medical care averaged across time intervals in the studies. Seventy-two percent (95% CI 67-77%, N = 6586, 12 findings) entered care within 4 months of diagnosis. Seventy-six percent (95% CI 66-84%, N = 561, 15 findings) entered care after testing HIV-positive in emergency/urgent care departments and 67% (95% CI 64-70%, N = 52 762, 13 findings) entered care when testing was done in community locations. With respect to retention in care, 59% (95% CI 53-65%, N = 75 655, 28 findings) had multiple HIV medical care visits averaged across assessment intervals of 6 months to 3-5 years. Retention was lower during longer assessment intervals. Entry and retention in HIV medical care in the United States are moderately high. Improvement in both outcomes will increase the success of a test and treat strategy.
Article
In 2006, the US Centers for Disease Control and Prevention (CDC) issued revised recommendations for HIV diagnostic testing and screening in health care settings.1 With these recommendations, the CDC advised that all 13- to 64-year-old patients in US health care settings undergo nontargeted screening for HIV—that is, be tested without regard to their actual or perceived risk for HIV and without regard to signs or symptoms of HIV infection. To facilitate large-scale screening, the CDC proposed fundamental changes to HIV testing methods. The CDC recommended that (1) an opt-out approach should be used to introduce HIV testing (patients are informed that they will be tested for HIV unless they decline); (2) patient permission for HIV testing should not be given through a separate signed consent form but can be considered part of the general medical consent for care (either implicitly or explicitly stated); and (3) HIV prevention counseling does not need to be performed at the time of testing.2
Article
The Centers for Disease Control and Prevention (CDC) recommends routine (nontargeted) opt-out HIV screening in health care settings, including emergency departments (EDs), where the prevalence of undiagnosed infection is 0.1% or greater. The utility of this approach in EDs remains unknown. To determine whether nontargeted opt-out rapid HIV screening in the ED was associated with identification of more patients with newly diagnosed HIV infection than physician-directed diagnostic rapid HIV testing. Quasi-experimental equivalent time-samples design in an urban public safety-net hospital with an approximate annual ED census of 55,000 patient visits. Patients were 16 years or older and capable of providing consent for rapid HIV testing. Nontargeted opt-out rapid HIV screening and physician-directed diagnostic rapid HIV testing alternated in sequential 4-month time intervals between April 15, 2007, and April 15, 2009. Number of patients with newly identified HIV infection and the association between nontargeted opt-out rapid HIV screening and identification of HIV infection. In the opt-out phase, of 28,043 eligible ED patients, 6933 patients (25%) completed HIV testing (6702 patients were screened; 231 patients were diagnostically tested). Ten of 6702 patients (0.15%; 95% CI, 0.07%-0.27%) who did not decline HIV screening in the opt-out phase had new HIV diagnoses, and 5 of 231 patients (2.2%; 95% CI, 0.7%-5.0%) who were diagnostically tested during the opt-out phase had new HIV diagnoses. In the diagnostic phase, of 29,925 eligible patients, 243 (0.8%) completed HIV testing. Of these, 4 patients (1.6%; 95% CI, 0.5%-4.2%) had new diagnoses. The prevalence of new HIV diagnoses in the opt-out phase (including those diagnostically tested) and in the diagnostic phase was 15 in 28,043 (0.05%; 95% CI, 0.03%-0.09%) and 4 in 29,925 (0.01%; 95% CI, 0.004%-0.03%), respectively. Nontargeted opt-out HIV screening was independently associated with new HIV diagnoses (risk ratio, 3.6; 95% CI, 1.2-10.8) when adjusting for patient demographics, insurance status, and whether diagnostic testing was performed in the opt-out phase. The median CD4 cell count for those with new HIV diagnoses in the opt-out phase (including those diagnostically tested) and in the diagnostic phase was 69/microL (IQR, 17-430) and 13/microL (IQR, 11-15) , respectively (P = .02). Nontargeted opt-out rapid HIV screening in the ED, vs diagnostic testing, was associated with identification of a modestly increased number of patients with new HIV diagnoses, most of whom were identified late in the course of disease.